Denali Therapeutics Inc. — Director's Dealing 2017

Dec 7, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Denali Therapeutics Inc. (DNLI)
CIK: 0001714899
Period of Report: 2017-12-07

Reporting Person: FIL Ltd (10% Owner, See Remark 1)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	416882	Direct
Common Stock	318158	Indirect
Common Stock	87393	Indirect
Common Stock	87124	Indirect
Common Stock	1121	Indirect
Common Stock	197	Indirect
Common Stock	300	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A-1 Convertible Preferred Stock	$		Common Stock (1397326)		Direct
Series A-1 Convertible Preferred Stock	$		Common Stock (1065616)		Indirect
Series A-1 Convertible Preferred Stock	$		Common Stock (293204)		Indirect
Series A-1 Convertible Preferred Stock	$		Common Stock (292303)		Indirect
Series A-1 Convertible Preferred Stock	$		Common Stock (3755)		Indirect
Series A-1 Convertible Preferred Stock	$		Common Stock (662)		Indirect
Series A-1 Convertible Preferred Stock	$		Common Stock (1008)		Indirect
Series A-2 Convertible Preferred Stock	$		Common Stock (28750)		Direct
Series A-2 Convertible Preferred Stock	$		Common Stock (21942)		Indirect
Series A-2 Convertible Preferred Stock	$		Common Stock (6027)		Indirect
Series A-2 Convertible Preferred Stock	$		Common Stock (6008)		Indirect
Series A-2 Convertible Preferred Stock	$		Common Stock (77)		Indirect
Series A-2 Convertible Preferred Stock	$		Common Stock (13)		Indirect
Series A-2 Convertible Preferred Stock	$		Common Stock (20)		Indirect
Series B-1 Convertible Preferred Stock	$		Common Stock (71875)		Direct
Series B-1 Convertible Preferred Stock	$		Common Stock (54854)		Indirect
Series B-1 Convertible Preferred Stock	$		Common Stock (15068)		Indirect
Series B-1 Convertible Preferred Stock	$		Common Stock (15021)		Indirect
Series B-1 Convertible Preferred Stock	$		Common Stock (193)		Indirect
Series B-1 Convertible Preferred Stock	$		Common Stock (34)		Indirect
Series B-1 Convertible Preferred Stock	$		Common Stock (51)		Indirect

Footnotes

F1: The Series A-1, A-2, and B-1 Convertible Preferred Stock are convertible on a one-for-one basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering, and have no expiration date.